UCLA Invents Newsletter
Newsletter published by: UCLA OIP-ISR November 2014




Dec. 05, 2014
FirstFridays @ OIP
Topic:  "Top Five HR Mistakes Made by Startups"
Speaker:  Lynne Vu, SPHR, Principle Human Capital Consultant

More Events


National Cancer Inst.

Sofie Biosciences Receives $1.5M Phase II SBIR Grant
UCLA startup, SOFIE BIOSCIENCES, announced that the National Cancer Institute (NCI) has awarded the company a Phase II Small Business Innovation Research (SBIR) contract for approximately $1.5M over two years. The award will support the further development of SOFIE's family of proprietary [18F]FAC imaging probes.
Vault Nano Inc.

Vault Nano Awarded $1M SBIR Grant for Drug Delivery
The $1 million award from the National Cancer Institute’s SBIR program will enable UCLA scientists and industry partners to take an innovative lung cancer treatment through the final steps toward its first clinical trial. The treatment combines an immunotherapy agent called CCL21 with a drug delivery nanotechnology.
Ann Wang

Blackstone Launchpad Opens for Bruin Entrepreneurs
Earlier this year, Blackstone Foundation announced its LaunchPad Program's expansion into the L.A. area with a three-year $3.5 million grant to UCLA and its partner institutions. The Launchpad at UCLA program aims to introduce entrepreneurship to undergraduate students as a viable career path and foster entrepreneurial skills.
CFTM Group Picture

App Design Competition Pairs Students, Researchers

The annual UCLA "Code for the Mission" app competition was launched by UCLA OIP-ISR and OIT to encourage the development of mobile apps that match the university’s mission of research, education, and service. Tech-savvy students were matched with UCLA researchers. $15,000 in prizes were awarded. 

Intellectual Property Announcements

New U.S. Patents Awarded

  • 8,858,950 - Delivery of pharmaceutical agents via the human insulin receptor  | W. Pardridge, et al.
  • 8,860,006 - Spin transistor having multiferroic gate dielectric  | K. Wang, et al.
  • 8,853,356 - Use of pentagastrin to inhibit gastric acid secretion or as a diuretic  | J. Pisegna, et al.
  • 8,852,320 - Preparation of metal-triazolate frameworks  | O. Yaghi, et al.
  • 8,846,066 - Methods and related compositions for reduction of fat and skin. . . | M. Kolodney, et al.
  • 8,845,554 - Method and apparatus for quantitative assessment of neuromotor. . . | M. Sarrafzadeh, et al.


New UCLA Technologies Available for Licensing



    UCLA Invents - October 2014
    • UCLA Announces Westwood Technology Transfer
    • UC Promotes Startups with New $250M Venture Capital Fund
    • Avalon Ventures and GSK Partnership Launches UCLA Startup
    • UCLA Startup NeuroSigma Inc. Set to IPO at $50M
    • UCLA Healthcare Startup SELFA Inc. Receives $1.6M Grant
    UCLA TechMatch Program for
    Startups and Established Companies

    Customized, automated service matches UCLA innovation with
    industry research and technology licensing interests.  Subscribe today.

    UCLA Invents Newsletter, Vol. 3, No. 3

    How to Subscribe

    Send editorial comments and corrections to:  
    Bob Nidever,  bnidever@research.ucla.edu

    Contributors: Neil Bajpayee, Howard Chang, Miles Gerson

    UCLA Invents is published by the UCLA Office of Intellectual Property & Industry Sponsored Research
    11000 Kinross Ave., Suite 200; Los Angeles, CA 90095 | tel. 310-794-0558 | http://oip.ucla.edu

    Copyright © 2014 The Regents of the University of California. All Rights Reserved.

    Share this